Our Practice
FINRA Form 211 and Rule 15c2-11
A company seeking broker-dealer quotations for an OTC security may need a sponsoring market maker or other qualified participant to satisfy Rule 15c2-11 and applicable FINRA requirements.
Capital Markets Law Group assists companies seeking broker-dealer quotations for an OTC security. The firm handles FINRA Form 211 applications, Rule 15c2-11 current information requirements, and the market-maker coordination that sits on top of them, so the advice accounts for both the application process and what the company will need to stay quoted after initiation.
What Does Rule 15c2-11 Require?
Rule 15c2-11 is an SEC rule that governs how broker-dealers initiate and maintain quotations. Before publishing a quotation, a broker must review specified information about the issuer. After initiation, the rule requires current information on a continuing basis, with own-account quotations subject to specific timing rules when information lapses:
- Specified issuer information must be reviewed before a quotation is published
- Current information must be maintained on a continuing basis after initiation
- Own-account quotations are subject to timing rules when information lapses
- Quotation initiation may proceed only where the rule's conditions are satisfied
What Is FINRA Form 211?
FINRA Form 211 is the application a sponsoring market maker files with FINRA to initiate quotation for a security. The application includes the issuer's information and supporting documentation, and FINRA reviews the filing before quotation begins:
- The sponsoring market maker files the application, not the issuer
- Supporting documentation accompanies the filing
- FINRA reviews the application before quotation begins
- Quotation initiation timing depends on the filing and FINRA's review
What Does the Issuer Owe Under the Rule?
The issuer's obligations under Rule 15c2-11 turn on its reporting framework. A company that reports through the SEC publishes through EDGAR, and OTC Markets links to those filings. A company that reports through an alternative framework publishes through OTC Markets' own disclosure platform. Either way, current information is what keeps the security quoted:
- Reporting through the SEC: filings through EDGAR, linked by OTC Markets
- Reporting through an alternative framework: disclosure through OTC Markets' platform
- Either route: current information is what keeps the security quoted
When Should Counsel Become Involved?
Before the application is filed. The common failure patterns happen when companies treat quotation as a marketing exercise rather than a regulatory process, so a late decision narrows the options. Counsel review before filing covers:
- Confirming the issuer's reporting framework and its conditions
- Reviewing whether the issuer's record holder base supports quotation
- Planning the documentation the application requires
- Coordinating transfer agent, DTC, and capitalization matters that surface alongside quotation
- Mapping the ongoing conditions the company must maintain after initiation
What Commonly Causes Problems?
Recurring issues in FINRA Form 211 and Rule 15c2-11 matters include:
- Applications filed before the issuer's record holder base is in place
- Documentation that does not match the issuer's actual reporting framework
- Assumptions that quotation initiation is a marketing exercise rather than a regulatory process
- Conditions maintained inconsistently after initiation
- Capitalization matters left unaddressed while the application is pending
What Alternatives Are Available?
The main structural choice is between staying quoted on OTC and pursuing a Nasdaq or NYSE American listing. A company that wants an exchange listing will need to satisfy the exchange's requirements, which are stricter than OTC's. Reg D and Reg A exemptions can also determine the kind of offering and disclosure the issuer can use while quoted.
How Does Capital Markets Law Group Help?
Our services may include:
- Confirming the issuer's reporting framework and its conditions
- Planning the documentation the application requires
- Coordinating Form 211 filings with sponsoring market makers
- Reviewing whether the issuer's record holder base supports quotation
- Mapping the ongoing conditions the company must maintain after initiation
- Coordinating transfer agent, DTC, and capitalization matters
- Advising on Reg D, Reg A, and other exemption choices
- Advising on the path to a Nasdaq or NYSE American listing
Keep Reading: Nasdaq and NYSE American Uplistings, Nasdaq Listing Applications and Uplisting Counsel, SEC Securities Offerings, Going Public and Form S-1 Registration Statements.
Frequently Asked Questions
Can a Lawyer File Form 211 for the Issuer?
No. The applicable broker-dealer makes the submission.
Does Completion of Form 211 Guarantee Active Trading?
No. It does not guarantee liquidity, investor interest, a particular quotation, or a trading price.
Does Current OTC Status Eliminate the Need for a Market Maker?
Not necessarily. The route depends on the security, its quotation history, available exceptions, and venue requirements.
What Is the Piggyback Exception?
It may permit broker-dealers to continue quotations when specified quotation and issuer-information conditions are satisfied.
Can Quotations Resume After a Trading Suspension?
Possibly, but a suspension may create substantial legal, disclosure, regulatory, and market-maker issues.
How Long Does Form 211 Review Take?
Processing time varies with the completeness of the submission, the issuer's history, and any questions FINRA or the sponsoring firm raises. Companies should not announce quotation dates until the process is substantially complete.
Get Started
Talk to Capital Markets Law Group About OTC Quotations
Capital Markets Law Group assists companies with Rule 15c2-11 readiness, Form 211 support, disclosure, reporting, and related OTC matters. Contact the firm before approaching a sponsoring market maker.